Thos:
Thank you for posting on the essence of what the core of this struggle is all about.
So, summarizing briefly, the IMS staff has developed a cell library technology as part of their 10 year long R&D effort. This breakthrough technology has significant use and value to industry firms, bringing their products/services to market in much more efficient schedules resulting in greater levels of profitability.
The company, as you discussed earlier, is not in bankruptcy due to abnormal debt. In fact, much of it as you explained, found on the record submitted recently is dubious at best. The problem, whether real or contrived, is one of cash-flow. Discussing the cash-flow situation is relevant because whoever covers it will enable and control the potential flow of a great deal of business and revenue for IMS over the next year. Ten years worth of built-up potential will be realized.
As you say, IMS represents the greatest of all speculation for an investor now. However, on the plus side, with the right leadership, the company is set to tap its potential right now. Covering debt, removing long-term liabilities will be achievable during this year, and will enable the company to promote the long-term growth we have been investing in to happen.
In my opinion, the struggle is well worth it. The risk for the financial backer to the shareholder committee is a healthy one, but what a gigantic opportunity. The reward to risk ratio is clearly a tremendous incentive.
My hope and concern is that those that have been following IMES, are aware of the true realities here. As some of said, this is a true "soap opera" drama being played out. It is not a typical Ch 11 case study- by any means! The struggle is worth it- I hope those interested in IMS are fully aware of all the facts. Stay up on things, get the current facts from the shareholder committee, and support the effort if you feel the risk is something you are up to!
DD |
